Regulatory troubles continue for Sun Pharma as the drug manufacturer’s ... Analysts at HSBC expect the FDA move to add to the regulatory overhang for the drugmaker, while those at Nomura ...
The US Food and Drug Administration (US FDA) has released a detailed report ... the regulator to achieve fully compliant status,” Sun Pharma had informed exchanges on the matter on April 11.
The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
Medtech startup EzeRx Health Tech Pvt Ltd, which counts drugmaker Sun Pharma as its largest investor, is in talks with at least two venture capital firms and a state-run company to raise fresh equity ...
Sun Pharma Advanced Research Company Ltd. announced the results of the interim analysis from the Proseek study, a global Phase 2 study in patients with early Parkinson’s Disease. The study ...
Mumbai-based pharmaceutical company, Sun Pharma Advanced Research Company Ltd. (SPARC), said it was abandoning its Phase 2 study on Vodobatinib for Parkinson's. The study was designed to evaluate ...